Status:
WITHDRAWN
Cardiometabolic and Mental Health in the RGV
Lead Sponsor:
University of Texas Rio Grande Valley
Conditions:
Microvessels
Carbohydrate Metabolism
Eligibility:
All Genders
18-75 years
Brief Summary
Microvascular insulin resistance has been shown to precede myocyte insulin resistance and impairments in metabolic function. However, there is no convincing data showing the relationship between impai...
Detailed Description
Metabolic flexibility is the ability to adjust fuel oxidation to fuel availability. The term is classically defined as the ability to switch from fat oxidation during fasting conditions to glucose oxi...
Eligibility Criteria
Inclusion
- Healthy people, those with T2D, or those with Alzheimer's Disease.
- 18-75 years
- having either a parent with type 2 diabetes or Alzheimer's, or no history for 2 generations
- non-smoking, weight-stable
Exclusion
- presence of microvascular disease
- smoking
- having gained or lost more than 5lbs in the last 3 months
- pregnancy
- having cancer, liver, or kidney disease within 5 years
Key Trial Info
Start Date :
January 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2028
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03436875
Start Date
January 1 2023
End Date
December 30 2028
Last Update
May 10 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas Rio Grande Valley - Cardiometabolic Exercise Lab
Brownsville, Texas, United States, 78520